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Abstract
Aims: To characterize a series of contemporary patients with alcohol-related Wernicke’s encephal-
opathy (WE) or Korsakoff’s syndrome (KS) and to update the current prognosis of disease.
Methods: Retrospective and prospective study of patients diagnosed with an alcohol-related WE or
KS between 2002 and 2011 in a tertiary hospital. Socio-demographic, alcohol use characteristics,
signs and symptoms, co-morbidity and blood parameters were obtained at admission. Patients
were followed up until 2013 and causes of death were ascertained through the review of charts.
Results: Sixty-one patients were included (51 with WE and 10 with KS). Among patients with WE,
78% were men and age at diagnosis was 57 years (interquartile range (IQR): 49–66). Twenty-three
percent fulfilled the classic WE triad. Regarding Caine’s criteria for WE, 70.6% presented with at
least two out of four signs or symptoms. Median follow-up of patients with WE syndrome was 5.3
years (IQR: 2.6–8.8), the cumulated mortality was 45% and death rate of 7.4 × 100 person-years
(95% confidence interval (CI): 4.8–10.9). Overall, 50% of patients would be expected to die within
8 years of WE episode and main causes of death included serious bacterial infections (44.5%) and
cancer (33.3%).
Conclusions: Survival of patients with an alcohol-related Wernicke–Korsakoff syndrome is poor;
pursuing treatment of alcohol use disorder and early diagnosis of thiamine deficiency is a priority
for improving clinical outcomes.
INTRODUCTION
Wernicke’s encephalopathy (WE) is an acute neurological dis-
ease due to thiamine deficiency. The clinical picture is character-
ized by the onset of mental status changes with confusion,
ophthalmoplegia and ataxia, as described by Carl Wernicke in
1881. Acute cases recognized early respond to treatment with thia-
mine, but in chronic forms or Korsakoff’s syndrome (KS) the dis-
ease evolves into a psychosis and memory deficits (Victor et al.,
1971, 1989).
Alcohol use disorder (AUD) is a recognized risk factor for the
development of Wernicke–Korsakoff syndrome in western countries;
ethanol contributes to a diminished capacity of the liver to store
vitamins and to the inhibition of thiamine transport across the intes-
tinal mucosa (Thomson, 2000). Some studies have determined that
up to 90% of WE cases are related to unhealthy alcohol use (i.e. a
chronic alcohol misuse associated with inadequate dietary intake of
thiamine) (Harper, 1983, 1995; Thomson, 2000), and that 13% of
patients with AUD develop WE (Harper et al., 1986).
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Thiamine, in its biologically active form thiamine pyrophos-
phate, is an essential coenzyme in several biochemical pathways in
the brain. The cerebellar vermis is the anatomical zone commonly
observed to be damaged by ethanol; the cerebellum and the brain-
stem structures, through a neuronal loss, are particularly sensitive to
a lack of thiamine, and this mechanism could be involved in the
reversible and irreversible neurological symptoms (Butterworth,
1993; Lavoie and Butterworth, 1995; Baker et al., 1999). One study
showed that 30% of patients with unhealthy alcohol use had signs
of cerebellar ataxia and 27–42% showed atrophy of the cerebellar
vermis, according to neuroimaging data (Maschke et al., 2005).
Studies have described the prevalence of WE as falling between
0.8 and 2.8% of the general population (Lishman, 1981; Charness
et al., 1989; Torvik, 1991). However, the prevalence reaches up to
12% among AUD patients, according to brain damage data obtained
during autopsies (Torvik et al., 1982).
The diagnosis of WE is clinical and often goes unnoticed (Sechi
and Serra, 2007; Galvin et al., 2010). In 1997, new clinical criteria
were included in order to improve the sensitivity of diagnosis com-
pared with the classic triad of WE, which is only seen in one in four
patients (Caine et al., 1997). Actually, neuroimaging techniques can
aid in the diagnosis of WE but the absence of abnormalities in mag-
netic resonance imaging (MRI) examinations does not exclude the dis-
ease; in fact, the sensitivity of WE diagnosis by MRI is 53% although
the specificity is high (93%) (Antunez et al., 1998). The misdiagnosis
of WE implies that the disease is undertreated thus increasing the risk
of chronic forms of the disease as described by Sergei Korsakoff in
1889. Some studies have reported that in AUD patients diagnosed
with WE, progression to KS was seen in 56–84% of cases (Victor
et al., 1971; Wood et al., 1986; Thomson and Marshall, 2006).
Studies conducted in past decades have estimated that mortality of
patients with WE is ~17%, and that 10% of patients die during the
acute phase of the disease (Victor et al., 1971, 1989). Nevertheless,
current data on mortality and long-term prognosis are scarce even
after the introduction of more sensitive diagnostic criteria and MRI
techniques.
In this study, we aimed to characterize a series of contemporary
patients with alcohol-related WE and KS. We hypothesized that
alcohol-related cases of the syndrome continue to be diverse in its
clinical presentation. Furthermore, we also looked at the severity of
clinical course and long-term prognosis of patients focusing on the
impact of unhealthy alcohol use in the survival of disease.
MATERIALS AND METHODS
Retrospective and prospective longitudinal study of patients diag-
nosed with alcohol-related WE and KS in a tertiary hospital in
Badalona, Spain, between 1 January 2002 and 31 December 2011.
The University Hospital Germans Trias i Pujol is a 500-bed facility
serving a population of 400,000 in an urban area north of
Barcelona, Spain. The hospital provides clinical and surgical services
including emergency medicine, intensive care, maternity and pediat-
ric care as well as >20 specialties including internal medicine, neur-
ology and general surgery. There are no specific beds for the
hospitalization of acute and chronic psychiatric conditions. The hos-
pital serves an average of 200 emergencies per day, and up to
20,000 discharges per year.
For the retrospective objective of study, clinical charts were
reviewed for the patients admitted between 1 January 2002 and
31 December 2011 and the following codes of the International
Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) were used: 291.1, alcohol-induced persisting amnestic
disorders; 294.0, amnestic disorder in conditions classified elsewhere;
and 265.1, other and unspecified manifestations of thiamine defi-
ciency. The ICD-9-CM codes were agreed upon by internists partici-
pating in a multi-center study on the incidence and treatment of WE
cases in Spain (Chamorro and Marcos, 2012). The disease coding sys-
tem follows the Spanish regulation of the whole of National Health
System hospitals in relation with hospital admittance episodes.
Disease codes were classified by Groups of Related Diagnosis (GRD)
in the version ‘All patients’ (AP-GRD v25.0) (Ministerio de Sanidad
Servicios Sociales e Igualdad, 2014), and recorded in a Minimum
Basic Data Set (MBDS) that included the principal diagnosis code and
nine secondary codes; codification was performed by the hospital
documentation unit and patients were classified according to whether
they presented WE or KS (Fig. 1).
Socio-demographic variables, clinical signs and symptoms of WE
(ataxia, ophthalmoplegia and mental changes/confusion) and Caine’s
criteria (Caine et al., 1997) (at least two out of dietary deficiency,
ocular disturbances, cerebellar dysfunction and altered mental state)
were collected through the revision of charts. In addition, informa-
tion on co-morbidity at admission, hematological and biochemical
parameters, and the length of stay were also variables of interest.
The clinical course of an acute WE episode was considered favor-
able if patients exhibited complete remission of the clinical signs and
symptoms at discharge. For the purposes of this study, the majority of
patients were followed up in the hospital outpatient clinics between
the date of discharge and 31 December 2013. In addition, cross-
checks with the national death registry were performed in all cases.
The study was approved by the Ethics Committee of the
Hospital Universitari Germans Trias I Pujol, and the research meth-
ods complied with the ethical norms for medical investigations and
good practice principles established in the Declaration of Helsinki.
Statistical analysis
Descriptive statistics were expressed as the median and interquartile
range (IQR) for continuous variables and as absolute frequencies
and percentages for categorical variables. The chi-square test and
Fisher’s F test for categorical variables and one-factor ANOVA for
continuous variables were used to explore differences in patient
characteristics.
Incidence rates were calculated in person-years (p-y); p-y repre-
sents the time that all patients contribute to a longitudinal study.
Rates in p-y are the quotient of the number of events observed dur-
ing the study period and the sum of all the individual follow-up
time. The long-term prognosis for WE was analyzed through
Kaplan–Meier survival curves using the log-rank test for the com-
parison of the curves in relation to the variables of interest.
Values of P < 0.05 were considered to be statistically significant.
The statistical analysis was performed with SPSS 15.0 (SPSS,
Chicago, IL, USA).
RESULTS
Between 1 January 2002 and 31 December 2011, 61 patients met
the criteria for inclusion; of them, 51 were diagnosed with WE and
10 with KS. The majority of the diagnoses (74.6%) were carried out
in the departments of Neurology and Internal Medicine. WE and KS
were found among the three principal diagnostic codes in 67% of
the cases. Among the 51 patients with WE, 78.4% were men,
median age at admission was 57 years (IQR: 49–66 years) and the
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length of stay was 10 days (IQR: 5–24 days). Socio-demographic
and clinical characteristics of patients are shown in Table 1.
Regarding symptoms and signs of WE, 60.8% of the patients pre-
sented with ocular disturbances, 82.4% with ataxia, 41.2% altered
mental state and 18 (35.3%) had dietary deficiencies. Overall, 63%
showed one or more symptom or sign, 23.5% fulfilled the classic WE
triad and 11.8% had neither signs nor symptoms of classic triad. As
to the diagnosis of WE according to Caine’s criteria, 70.6% of
patients had two out of four criteria, 17.6% showed all four and
9.8% none. The majority of patients without signs or symptoms of
disease presented with nausea and vomiting at admission; in these
patients, MRI and/or levels of thiamine were used to confirm WE.
At the time of WE, 55% of the patients were tobacco smokers,
11.8% of patients had diabetes mellitus, 15.7% hypertension and
25.5% chronic liver disease. With respect to biological para-
meters, median hemoglobin was 13.4 g/dl (IQR: 12.4–14.7 g/dl),
mean corpuscular volume was 101 fl (IQR: 96–108 fl), leukocyte
count was 9 × 109 cells/l (IQR: 8–12 × 109 cells/l) and platelet
count was 198 × 109 cells/l (IQR: 119–257 × 109 cells/l). The clin-
ical and biological characteristics of patients are shown in
Table 2. Complete recovery of those with an acute WE episode
was obtained in 42.6% of the cases.
In-hospital mortality
Two patients died during their hospital stay. The first died of heart
failure and the autopsy showed dilated hypertrophic cardiomyop-
athy and left atrium thrombosis. The second, admitted for ataxia
and delirium, presented with severe malnutrition and subsequently
developed gastrointestinal bleeding, kidney failure, urinary sepsis
(Escherichia coli) and died 44 days after admission.
Follow-up and outcomes
Median follow-up after discharge was 5.3 years (IQR: 2.6–8.8 years).
The majority (80%) of patients diagnosed with WE were regularly
visited in the outpatient clinics and 20% were lost to follow-up. The
cumulative mortality at the end of the study, in 31 December 2013,
was 45.1% (23 patients); overall mortality rate was 7.4 × 100 p-y
(95% CI: 4.8–10.9 × 100 p-y). In the 23 patients who died during
follow-up, time between hospital discharge and death was 4.8 years
(95% CI: 1.8–7.0 years). Overall, 44.5% of deaths were due to ser-
ious bacterial infections and 33.3% were due to cancer. More infor-
mation on clinical outcomes is shown in Table 3.
Figure 2 shows the Kaplan–Meier survival estimates for WE.
Median of survival was 8 years (95% CI: 5.3–10.7 years) and mortality
was not associated with sex (P = 0.408), medical co-morbidity at
admission (liver disease, P = 0.791; hypertension, P = 0.419; gastro-
intestinal surgery, P = 0.839; cancer, P = 0.555) and clinical signs of
WE (classic triad, P = 0.940; Caine’s criteria, P = 0.810). Although not
statistically significant, patients older than 57 years (P = 0.106) at
admission and those with diabetes mellitus (P = 0.520) had lower sur-
vival (5.9 and 5.1 years, respectively).
Overall, two thirds of patients continued to drinking alcohol
after discharge, 6% of presented with a new WE episode, 25% were
diagnosed with cancer (incidence rate, 5 × 100 p-y; 95% CI:
2.5–9.3 × 100 p-y) and 25% with progressive cognitive impairment.
Korsakoff’s syndrome
Patients with KS (n = 10) were predominantly male (90%) and older
(60.5 years (IQR: 51.3–68.4 years)) than those with WE. One
patient died during hospitalization due to bacterial infection in the
context of pharyngeal carcinoma, and three died during follow-up
(mortality rate 7.3 × 100 p-y (95% CI: 2.3–17.7 × 100 p-y)); causes
of death included respiratory tract infections, liver disease and can-
cer. The four deceased patients had been institutionalized due to
marked cognitive impairment.
DISCUSSION
WE is an acute, neuropsychiatric syndrome leading to permanent
brain lesions if treatment with thiamine is delayed. Patients with
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• 22  with amnestic syndromes
not related with WE or KS
• 4 without clinical information
• 4 with non alcohol-related WE
19 readmissions
Fig. 1. Selection of the study population. Patients with WE and KS diagnosed in
a tertiary hospital. Hospital Universitari Germans Trias i Pujol. Badalona, Spain.
Table 1. Characteristics of patients with WE admitted between
January 2002 and December 2011
N = 51, n (%)
Male 40 (78.4)





≥1 sign or symptom of WE 32 (62.7)
Gastrointestinal symptoms 7 (13.7)
Malaise, fever, constitutional syndrome 7 (13.7)
Treatment of AUD 2 (3.9)
Othera 3 (6.0)
Duration of admission (days), median (IQR) 10 (5–24)
ICD-9-CM codes
265.1—Unspecified manifestations of thiamine
deficiency
23 (45.1)
291.1—Alcohol-induced amnestic disorders 25 (49.0)
294.0—Amnestic disorder 3 (5.9)
Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
aSeizures in one case, polyneuropathy in one case and femur fracture in
one case.
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AUD are particularly at risk of developing thiamine deficiency if they
are malnourished or have severe co-morbidities. This study in an
urban area confirms the relative poor survival of disease in a contem-
porary series of middle-aged patients. In fact, median survival after
an episode of WE is 8 years, which confirms the poor prognosis of
the disease. To our knowledge, this is the first longitudinal study that
analyzes long-term outcomes of the syndrome in AUD patients.
It is interesting to note that with respect to causes of death, 50%
were related to serious bacterial infections, the majority being
respiratory tract infections in the context of chronic AUD and
chronic liver disease. One longitudinal study from our group
reported that among patients seeking treatment of AUD the main
causes of death were liver related, cancer and cardiovascular disease
(Rivas et al., 2013). However, neuropathology necropsies of 51 WE
cases established that 52% of deaths were caused by bronchopneu-
monia (Harper, 1979); another study with post-mortem analysis
reported that up to 77% of WE/KS patients die of infections (Victor
et al., 1989). Furthermore, a recent study in a cohort of patients
with acute WE shows that half of them had serious infections (i.e.
pneumonia, urinary tract and abdominal), thus suggesting a rela-
tionship between thiamine deficiency and the risk of infection
(Wijnia et al., 2016).
In this study, cancer was the second cause of death which is in
agreement with previous studies. Moreover, it is well known that
the combination of alcohol consumption and tobacco smoking
(55% of our study population) is associated with an increased risk
for certain malignant tumors (Lee and Hashibe, 2014). In this
regard, the association between unhealthy alcohol use and some
malignancies has been well established, but research is needed to
analyze the role of thiamine deficiency in the risk of cancer (Galvin
et al., 2010).
Systemic inflammation, oxidative stress and immune alterations
are involved in the pathogenesis of diseases associated with AUD.
The oxidative stress in these patients could have been induced not
only by alcohol itself but also by thiamine deficiency (Sechi et al.,
2016). It is known that alcohol consumption causes oxidative stress
leading to impair cellular functions such as proliferation, apoptosis
and inflammatory response (Napoli et al., 2001; Grasselli et al.,
2014; Rajbanshi and Pandanaboina, 2014). On the other hand, low
levels of thiamine may lead to a decreased α-ketoglutarate dehydro-
genase activity, which triggers a cascade of alterations that increase
the oxidative stress.
Also regarding mortality, 10% of WE cases from this study died
during the episode. While there is not sufficient data on mortality
during the acute phase of WE, this result is in the lower range of
previous studies (Victor et al., 1989; Chamorro et al., 2017).
Interestingly, one in four patients with WE showed progressive
cognitive impairment during follow-up. This finding is not surpris-
ing considering that 50% of patients continued to drinking alcohol
and that thiamine pyrophosphate is an essential coenzyme in differ-
ent biochemical pathways in the brain. A recent study among
middle-aged participants suggests that heavy drinking is associated
with more rapid decline in cognitive function (Sabia et al., 2014).
Underdiagnosis of WE and heterogeneity of thiamine doses for
the treatment of the disease is widely recognized (Sechi and Serra,
2007; Galvin et al., 2010; Thomson et al., 2013). The high percent-
age of undiagnosed WE has been associated with the low recogni-
tion of clinical manifestations, the lack of sensitive diagnostic
markers and the low detection of unhealthy alcohol use by history
taking. In this study, the proportion of patients with classic WE
symptoms is similar to that previously described (15–30%) (Harper
et al., 1986; Munir et al., 2001). In contrast, the percentage of
patients with mental confusion at admission (33.3%) was lower
than observed in other studies (Harper et al., 1986), which may sug-
gest incomplete assessment of the condition at emergency room
admissions where initial physical examinations might be centered in
the level of consciousness.
On the other hand, the percentage of patients without clinical
signs (12%) of the classic triad was lower than in previous series
(Harper et al., 1986). In the context of an acute episode of WE,
signs and symptoms such as nausea, vomiting, weakness, anxiety or
Table 2. Clinical and biological characteristics of patients with WE
admitted to a tertiary hospital between January 2002 and
December 2011
N = 51, n (%)




Caine’s criteriaa 36 (70.6)
Dietary deficiency 18 (35.3)
Ocular disturbances 31 (60.8)
Cerebellar dysfunction 42 (82.4)
Altered mental state 21 (41.2)
Co-morbidity at admission
Liver disease 13 (25.5)
Hypertension 8 (15.7)
Gastrointestinal surgeryb 5 (9.8)
Diabetes mellitus 6 (11.8)
Cancer 3 (5.9)
Blood parameters at admission
Hemoglobin (g/dl) (n = 49) 13.4 (12.4–14.7)
Mean corpuscular volume (fl) (n = 45) 101 (96–108)
Leukocytes (×109 cells/l) (n = 49) 9 (8–12)
Platelets (×109 cells/l) (n = 48) 198 (119–257)
Glycemia (mg/dl) (n = 46) 113 (95–145)
Urea (mg/dl) (n = 44) 31 (20.6–39.5)
Sodium (mEq/l) (n = 47) 135 (133–138)
Aspartate aminotransferase (U/l) (n = 43) 56 (32–104)
Alanine aminotransferase (U/l) (n = 35) 31 (23–47)
Gamma glutamyl transferase (U/l) (n = 31) 124 (37–243)
aAt least two out of four criteria are necessary in WE.
bCholecystectomy in three cases and gastrectomy in two cases.
Table 3. Outcomes of interest at the end of study
N = 51, n (%)
Total follow-up (person-years) 310
Median follow-up (years) [IQR] 5.3 [2.6–8.8]
Cumulative mortality 23 (45.1)
Death rate [95% CI] (×100 p-y) 7.4 [4.8–10.9]
Age at death [IQR] (years) 65 [54–76]
Causes of death (N = 18)a
Infection 8 (44.5)
Cancer 6 (33.3)
Severe malnutrition and medical co-morbidity 2 (11.1)
Heart failure 2 (11.1)
Cumulative mortality and causes of death in 51 patients with an alcohol-
related episode of WE.
aIn five patients, the cause of death was unknown.
4 Alcohol and Alcoholism
emotional changes may appear (Thomson et al., 2008a, 2008b). In
our study, up to 14% of the patients suffered from vomiting at
admission and the majority had neither classic WE symptoms nor
the Caine’s clinical criteria (data not shown). Since diagnosis of the
disease remains clinical, attempts are underway to find markers for
increasing the sensitivity of diagnosis. A recent review of biomarkers
associated with Wernicke–Korsakoff highlights the poor results
obtained until now, although certain markers of microglial activa-
tion (CD68, leukocyte antigen-DR in brain tissue and lactate in ser-
um and cerebrospinal fluid) may be associated with delirium in
thiamine deficiency (Wijnia and Oudman, 2013; Sechi et al., 2016)
The present study found that survival was reduced in WE
patients with diabetes mellitus. The association between unhealthy
alcohol use and the metabolic complications of diabetes mellitus is
recognized (Pietraszek et al., 2010; Kim and Kim, 2012). In add-
ition, thiamine plays a role in the carbohydrate metabolism, and dia-
betic patients with AUD have an increased risk of developing WE
(Chamorro et al., 2009; Wijnia et al., 2012). On the other hand, it
is well known that supplementation with carbohydrates can precipi-
tate thiamine deficiency and the appearance of WE (Sechi and Serra,
2007). In any case, these findings suggest that assessment of co-
morbidity is relevant in the prognosis WE (Rivas et al., 2013).
It is noteworthy that survival of WE patients in this study was
not associated with age, sex or clinical presentation of the disease.
The lack of statistically significant associations may be related not
only to the small sample size but also to the few clinical variables
available. In addition, key cofactors such as malnutrition, alcohol-
related liver disease and parameters measuring systemic inflamma-
tion were not collected. In patients with AUD, surrogate markers of
chronic inflammation have been associated with poor prognosis
(Fuster et al., 2015). This study has other limitations that should be
mentioned. First, doses of thiamine for treating the WE episode
were not available; in this sense, a recent review on the prevention
and treatment of WE and KS concludes that there is insufficient evi-
dence to guide clinicians in doses, frequency, route of administration
and duration of the treatment (Day et al., 2013). Second, MRI was
not available in the majority of cases; MRI is regarded as the most
valuable neuroimaging technique aiding in the diagnosis of WE.
Third, incidence of WE could have been underestimated if patients
with alcohol-related delirium, encephalopathy, cognitive impairment
or psychoses were misclassified. Finally, data on history of alcohol
consumption and nutrition are scarce partly because this informa-
tion is poorly recorded in clinical charts. Rather, the strength of this
study relays in the long-term follow-up and clinical outcomes of
patients that allowed us to update the prognosis of a preventable
disease. Additional studies are required to identify AUD patients at
risk of developing both WE and KS.
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